---
aliases: Omadacycline tosylate, Nuzyra
---
- 用於治療
	- community-acquired bacterial pneumonia (CABP)
	- acute bacterial skin and skin structure infections (ABSSSI)
- 靜脈注射和口服
- broad spectrum
- 對 G-(-)，G-(+), aerobes, anaerobes, and atypical pathogens 有效
- C9 aminomethyl group
	- 增加抗菌活性
	- 增加 ribosomal protection proteins and efflux pump mechanisms 抗性
- C4 epimerization 自然發生
- MOA
	- 與 ribosome 30S subunit 結合
	- 抑制蛋白質合成
- Pharmacokinetics
	- 空腹時口服
	- 血漿濃度高峰出現在 1-4 hours
	- 半衰期 17.6 hours
	- 不被代謝
	- 與血漿蛋白結合弱
	- 主要透過 feces 排除
- Adverse Effects
	- nausea
	- vomiting
	- infusion site reactions
	- alanine aminotransferase increase
	- aspartate aminotransferase increase
	- g-glutamyltransferase increase
	- hypertension
	- headache 
	- diarrhea 腹瀉
	- insomnia 失眠
	- constipation 便秘

![[Pasted image 20230502225201.png]]